University of Vermont
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1791-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.uvm.edu
Exploring the Optimal Duration of a Group-based Online Behavioral Weight Loss Program
Not Applicable
Withdrawn
- Conditions
- Obesity and Overweight
- Interventions
- Behavioral: Four Month Duration Online Behavioral Weight Loss ProgramBehavioral: Six Month Duration Online Behavioral Weight Loss Program
- First Posted Date
- 2020-11-13
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- University of Vermont
- Registration Number
- NCT04628533
- Locations
- 🇺🇸
Behavioral Weight Management Program/Univ of Vermont, Burlington, Vermont, United States
🇺🇸University of South Carolina, Columbia, South Carolina, United States
Start Treatment and Recovery for Opioid Use Disorder
Not Applicable
Completed
- Conditions
- Opioid-use DisorderOpioid Medication Assisted TreatmentMental Disorder
- Interventions
- Other: Bridge Clinic
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 104
- Registration Number
- NCT04505540
- Locations
- 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States
PACE Vape Messaging Study
Not Applicable
Completed
- Conditions
- VapingE-cigarette UseElectronic Cigarette Use
- Interventions
- Behavioral: Vape Messaging Intervention
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 569
- Registration Number
- NCT04450537
- Locations
- 🇺🇸
University of Vermont, Burlington, Vermont, United States
COVID Cohort Study
Terminated
- Conditions
- COVID-19Acute Respiratory Failure
- Interventions
- Other: COVID-19+ observational
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2021-02-12
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 16
- Registration Number
- NCT04393155
- Locations
- 🇺🇸
University of Vermont College of Medicine, Burlington, Vermont, United States
Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults
Not Applicable
Completed
- Conditions
- Nicotine Dependence, Cigarettes
- Interventions
- Behavioral: Web + text smoking cessation intervention
- First Posted Date
- 2020-05-07
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 437
- Registration Number
- NCT04379388
- Locations
- 🇺🇸
University of Vermont, Burlington, Vermont, United States
Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer
Phase 1
- Conditions
- Lung Cancer Metastatic
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2022-05-23
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 9
- Registration Number
- NCT04311762
- Locations
- 🇺🇸
University of Vermont, Burlington, Vermont, United States
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy
Terminated
- Conditions
- Prostatic Neoplasm
- Interventions
- Diagnostic Test: Fluciclovine PET/CT using a digital PET/CT
- First Posted Date
- 2020-01-21
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 22
- Registration Number
- NCT04234399
- Locations
- 🇺🇸
UVM Medical Center, Burlington, Vermont, United States
Cholinergic Health After Menopause (CHAMP)
Early Phase 1
Recruiting
- Conditions
- Postmenopausal SymptomsAgingAlzheimer Disease
- Interventions
- Drug: Cholinergic antagonist
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 120
- Registration Number
- NCT04129060
- Locations
- 🇺🇸
University of Vermont, Burlington, Vermont, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Prolonged Exposure Therapy for PTSD and Opioid Use Disorder
Not Applicable
Completed
- Conditions
- Opioid-use DisorderPost Traumatic Stress Disorder
- Interventions
- Behavioral: Prolonged Exposure TherapyBehavioral: Attendance-based monetary incentives
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 52
- Registration Number
- NCT04104022
- Locations
- 🇺🇸
University of Vemont, Burlington, Vermont, United States
Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder
Phase 2
Active, not recruiting
- Conditions
- Tobacco Use Disorder
- Interventions
- Other: Cigarettes with varying nicotine contentOther: E-Cigarettes
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 310
- Registration Number
- NCT04092101
- Locations
- 🇺🇸
Shirley Plucinski, Burlington, Vermont, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath